IBDEI11F ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37638,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,37638,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,37639,0)
 ;;=C50.912^^140^1868^8
 ;;^UTILITY(U,$J,358.3,37639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37639,1,3,0)
 ;;=3^Malignant neoplasm of left female breast,unspec site
 ;;^UTILITY(U,$J,358.3,37639,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,37639,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,37640,0)
 ;;=C64.2^^140^1868^9
 ;;^UTILITY(U,$J,358.3,37640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37640,1,3,0)
 ;;=3^Malignant neoplasm of left kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,37640,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,37640,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,37641,0)
 ;;=C61.^^140^1868^10
 ;;^UTILITY(U,$J,358.3,37641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37641,1,3,0)
 ;;=3^Malignant neoplasm of prostate
 ;;^UTILITY(U,$J,358.3,37641,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,37641,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,37642,0)
 ;;=C34.91^^140^1868^11
 ;;^UTILITY(U,$J,358.3,37642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37642,1,3,0)
 ;;=3^Malignant neoplasm of right bronchus/lung,unspec part
 ;;^UTILITY(U,$J,358.3,37642,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,37642,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,37643,0)
 ;;=C50.911^^140^1868^12
 ;;^UTILITY(U,$J,358.3,37643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37643,1,3,0)
 ;;=3^Malignant neoplasm of right female breast,unspec site
 ;;^UTILITY(U,$J,358.3,37643,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,37643,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,37644,0)
 ;;=C64.1^^140^1868^13
 ;;^UTILITY(U,$J,358.3,37644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37644,1,3,0)
 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,37644,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,37644,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,37645,0)
 ;;=C44.99^^140^1868^14
 ;;^UTILITY(U,$J,358.3,37645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37645,1,3,0)
 ;;=3^Malignant neoplasm of skin,Oth Spec
 ;;^UTILITY(U,$J,358.3,37645,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,37645,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,37646,0)
 ;;=C79.51^^140^1868^15
 ;;^UTILITY(U,$J,358.3,37646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37646,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,37646,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,37646,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,37647,0)
 ;;=C79.52^^140^1868^16
 ;;^UTILITY(U,$J,358.3,37647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37647,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone marrow
 ;;^UTILITY(U,$J,358.3,37647,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,37647,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,37648,0)
 ;;=D47.4^^140^1869^29
 ;;^UTILITY(U,$J,358.3,37648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37648,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,37648,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,37648,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,37649,0)
 ;;=D50.9^^140^1869^1
 ;;^UTILITY(U,$J,358.3,37649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37649,1,3,0)
 ;;=3^Anemia, iron deficiency
 ;;^UTILITY(U,$J,358.3,37649,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,37649,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,37650,0)
 ;;=D64.9^^140^1869^2
 ;;^UTILITY(U,$J,358.3,37650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37650,1,3,0)
 ;;=3^Anemia, unspecified
 ;;^UTILITY(U,$J,358.3,37650,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,37650,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,37651,0)
 ;;=D75.89^^140^1869^3
 ;;^UTILITY(U,$J,358.3,37651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37651,1,3,0)
 ;;=3^Blood & blood forming organ disease, oth spec
 ;;^UTILITY(U,$J,358.3,37651,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,37651,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,37652,0)
 ;;=D89.2^^140^1869^16
 ;;^UTILITY(U,$J,358.3,37652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37652,1,3,0)
 ;;=3^Hypergammaglobulinemia, unspecified
 ;;^UTILITY(U,$J,358.3,37652,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,37652,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,37653,0)
 ;;=E03.9^^140^1869^24
 ;;^UTILITY(U,$J,358.3,37653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37653,1,3,0)
 ;;=3^Hypothyroidism, unspecified
 ;;^UTILITY(U,$J,358.3,37653,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,37653,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,37654,0)
 ;;=E05.90^^140^1869^30
 ;;^UTILITY(U,$J,358.3,37654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37654,1,3,0)
 ;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
 ;;^UTILITY(U,$J,358.3,37654,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,37654,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,37655,0)
 ;;=E08.42^^140^1869^10
 ;;^UTILITY(U,$J,358.3,37655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37655,1,3,0)
 ;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,37655,1,4,0)
 ;;=4^E08.42
 ;;^UTILITY(U,$J,358.3,37655,2)
 ;;=^5002524
 ;;^UTILITY(U,$J,358.3,37656,0)
 ;;=E09.42^^140^1869^11
 ;;^UTILITY(U,$J,358.3,37656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37656,1,3,0)
 ;;=3^DM drug-induced w/ neurological compl w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,37656,1,4,0)
 ;;=4^E09.42
 ;;^UTILITY(U,$J,358.3,37656,2)
 ;;=^5002566
 ;;^UTILITY(U,$J,358.3,37657,0)
 ;;=E10.42^^140^1869^4
 ;;^UTILITY(U,$J,358.3,37657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37657,1,3,0)
 ;;=3^DM Type 1 w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,37657,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,37657,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,37658,0)
 ;;=E10.65^^140^1869^5
 ;;^UTILITY(U,$J,358.3,37658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37658,1,3,0)
 ;;=3^DM Type 1 w/ hyperglycemia
 ;;^UTILITY(U,$J,358.3,37658,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,37658,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,37659,0)
 ;;=E10.9^^140^1869^6
 ;;^UTILITY(U,$J,358.3,37659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37659,1,3,0)
 ;;=3^DM Type 1 w/o complications
 ;;^UTILITY(U,$J,358.3,37659,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,37659,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,37660,0)
 ;;=E11.42^^140^1869^7
 ;;^UTILITY(U,$J,358.3,37660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37660,1,3,0)
 ;;=3^DM Type 2 w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,37660,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,37660,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,37661,0)
 ;;=E11.65^^140^1869^8
 ;;^UTILITY(U,$J,358.3,37661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37661,1,3,0)
 ;;=3^DM Type 2 w/ hyperglycemia
 ;;^UTILITY(U,$J,358.3,37661,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,37661,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,37662,0)
 ;;=E11.9^^140^1869^9
 ;;^UTILITY(U,$J,358.3,37662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37662,1,3,0)
 ;;=3^DM Type 2 w/o complications
 ;;^UTILITY(U,$J,358.3,37662,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,37662,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,37663,0)
 ;;=E13.42^^140^1869^12
 ;;^UTILITY(U,$J,358.3,37663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37663,1,3,0)
 ;;=3^DM oth w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,37663,1,4,0)
 ;;=4^E13.42
 ;;^UTILITY(U,$J,358.3,37663,2)
 ;;=^5002686
 ;;^UTILITY(U,$J,358.3,37664,0)
 ;;=E16.2^^140^1869^22
 ;;^UTILITY(U,$J,358.3,37664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37664,1,3,0)
 ;;=3^Hypoglycemia, unspecified
 ;;^UTILITY(U,$J,358.3,37664,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,37664,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,37665,0)
 ;;=E46.^^140^1869^26
 ;;^UTILITY(U,$J,358.3,37665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37665,1,3,0)
 ;;=3^Malnutrition, protein-calorie, unspec
 ;;^UTILITY(U,$J,358.3,37665,1,4,0)
 ;;=4^E46.
 ;;^UTILITY(U,$J,358.3,37665,2)
 ;;=^5002790
 ;;^UTILITY(U,$J,358.3,37666,0)
 ;;=E53.8^^140^1869^31
